Natriuresis-guided diuretic therapy improves diuresis and natriuresis in patients with heart failure Medha Baranwal4 Sept 2023 10:45 AM ISTNetherlands: A recent study published in Nature Medicine suggests that natriuresis-guided therapy could be a first step toward personalized treatment...
Torsemide and furosemide show no significant difference in all-cause mortality in HF patients: JAMA Dr. Mahalakshmi Sivashankaran28 March 2023 11:00 AM ISTUSA: A recent Clinical Trial called TRANSFORM-HF, published in JAMA, has found that torsemide and furosemide, two commonly used loop diuretics for...
SGLT2 inhibitors with conventional diuretics lower all-cause mortality in HF patients Jacinthlyn Sylvia11 Jan 2023 11:15 AM ISTA systematic review of nine randomized controlled trials found that the addition of SGLT2 inhibitors (SGLT2i) to conventional diuretic therapy for...
Do loop diuretics reduce mortality in ICU patients with fluid overload? Dr. Hiral patel22 July 2022 8:00 PM ISTDenmark: A new study showed very low certainty of the evidence, concerning the effect of loop diuretics on mortality and serious adverse events in...
Heart Failure 2021 Update: What physicians need to know dr. Abhimanyu Uppal14 May 2021 12:45 PM ISTHeart failure is a progressive chronic syndrome characterized by decrease in functional status and quality of life, and an increased morbidity and...
Osteoporosis may independently predict worse outcomes in CHF: Study Dr Kartikeya Kohli24 Dec 2020 5:45 PM ISTThe clinical significance of osteoporosis in chronic heart failure (CHF) remains unclear. Researchers of Japan have found that increased use of loop...
Empagliflozin plus loop diuretics significantly increase urine volume in diabetes with HF Medha Baranwal10 Nov 2020 10:15 AM ISTUK: The use of SGLT2 inhibitor empagliflozin in combination with loop diuretics in patients with type 2 diabetes (T2D) and heart failure, helps in...
